Mahmood, Niaz
Arakelian, Ani
Szyf, Moshe
Rabbani, Shafaat A.
Funding for this research was provided by:
Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre (PJT-156225, MOP 130410, MOP 130410)
Article History
Received: 4 December 2022
Revised: 27 December 2023
Accepted: 25 January 2024
First Online: 1 April 2024
Competing interests
: MS is the founder of HKG Epitherapeutics and Montreal EpiTerapia. All the other authors declare no competing financial interests.
: All in vivo experiments involving transgenic mice described in the present study were performed in compliance with a protocol approved by the McGill University Facility Animal Care Committee.